- Home
- FGEN vs ZCMD Comparison
FGEN vs ZCMD Comparison
Compare FGEN & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- ZCMD
- Stock Information
- Founded
- FGEN 1993
- ZCMD 2012
- Country
- FGEN United States
- ZCMD China
- Employees
- FGEN N/A
- ZCMD N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- FGEN Health Care
- ZCMD Real Estate
- Exchange
- FGEN Nasdaq
- ZCMD Nasdaq
- Market Cap
- FGEN 33.5M
- ZCMD 29.0M
- IPO Year
- FGEN 2014
- ZCMD 2020
- Fundamental
- Price
- FGEN $5.85
- ZCMD $1.18
- Analyst Decision
- FGEN Strong Buy
- ZCMD
- Analyst Count
- FGEN 1
- ZCMD 0
- Target Price
- FGEN $250.00
- ZCMD N/A
- AVG Volume (30 Days)
- FGEN 61.5K
- ZCMD 658.1K
- Earning Date
- FGEN 08-05-2025
- ZCMD 01-01-0001
- Dividend Yield
- FGEN N/A
- ZCMD N/A
- EPS Growth
- FGEN N/A
- ZCMD N/A
- EPS
- FGEN N/A
- ZCMD N/A
- Revenue
- FGEN $6,996,000.00
- ZCMD $15,864,773.00
- Revenue This Year
- FGEN N/A
- ZCMD N/A
- Revenue Next Year
- FGEN N/A
- ZCMD N/A
- P/E Ratio
- FGEN N/A
- ZCMD N/A
- Revenue Growth
- FGEN N/A
- ZCMD N/A
- 52 Week Low
- FGEN $4.50
- ZCMD $0.95
- 52 Week High
- FGEN $38.25
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- FGEN 43.29
- ZCMD 49.32
- Support Level
- FGEN $5.37
- ZCMD $1.12
- Resistance Level
- FGEN $5.73
- ZCMD $1.24
- Average True Range (ATR)
- FGEN 0.41
- ZCMD 0.13
- MACD
- FGEN 0.07
- ZCMD -0.00
- Stochastic Oscillator
- FGEN 77.78
- ZCMD 26.71
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.